Concord Days Sales Outstanding from 2010 to 2024

CCM Stock  USD 5.00  0.56  12.61%   
Concord Medical Days Sales Outstanding yearly trend continues to be very stable with very little volatility. Days Sales Outstanding is likely to drop to 47.42. During the period from 2010 to 2024, Concord Medical Days Sales Outstanding quarterly data regression pattern had sample variance of  5,899 and median of  167.63. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
49.91801296
Current Value
47.42
Quarterly Volatility
76.80815103
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord Medical's main balance sheet or income statement drivers, such as Interest Expense of 174 M, Selling General Administrative of 190.2 M or Total Revenue of 458 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.12 or Days Sales Outstanding of 47.42. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
  
Check out the analysis of Concord Medical Correlation against competitors.

Latest Concord Medical's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Concord Medical Services over the last few years. It is Concord Medical's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Concord Medical's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Concord Days Sales Outstanding Regression Statistics

Arithmetic Mean172.67
Geometric Mean152.89
Coefficient Of Variation44.48
Mean Deviation56.34
Median167.63
Standard Deviation76.81
Sample Variance5,899
Range294
R-Value(0.69)
Mean Square Error3,290
R-Squared0.48
Significance0
Slope(11.93)
Total Sum of Squares82,593

Concord Days Sales Outstanding History

2024 47.42
2023 49.92
2022 100.72
2021 98.16
2020 167.63
2019 200.51
2018 222.76

About Concord Medical Financial Statements

Concord Medical investors utilize fundamental indicators, such as Days Sales Outstanding, to predict how Concord Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Sales Outstanding 49.92  47.42 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out the analysis of Concord Medical Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.98)
Revenue Per Share
107.978
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.04)
Return On Equity
(0.32)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.